In a study examining the effects of metformin on cancer cells, metformin was observed to strongly suppress HO-1 expression in cervical cancer HeLa cells, and HO-1 inhibition provided metformin with antiproliferative effects [45]. The gene discussed is HMOX1; the disease is cervical carcinoma.